Literature DB >> 12547694

Complement in ischemia reperfusion injury.

Niels C Riedemann1, Peter A Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12547694      PMCID： PMC1851148          DOI： 10.1016/S0002-9440(10)63830-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  56 in total

1.  Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex.

Authors:  W G Austen; C Kyriakides; J Favuzza; Y Wang; L Kobzik; F D Moore; H B Hechtman
Journal:  Surgery       Date:  1999-08       Impact factor: 3.982

2.  Complement activation after oxidative stress: role of the lectin complement pathway.

Authors:  C D Collard; A Väkevä; M A Morrissey; A Agah; S A Rollins; W R Reenstra; J A Buras; S Meri; G L Stahl
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x.

Authors:  K Zacharowski; M Otto; G Hafner; H C Marsh; C Thiemermann
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45.

Authors:  P R Taylor; J T Nash; E Theodoridis; A E Bygrave; M J Walport; M Botto
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

5.  Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion.

Authors:  G Horstick; A Heimann; O Götze; G Hafner; O Berg; P Böhmer; P Becker; H Darius; H J Rupprecht; M Loos; S Bhakdi; J Meyer; O Kempski
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

6.  Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

Authors:  J C Fitch; S Rollins; L Matis; B Alford; S Aranki; C D Collard; M Dewar; J Elefteriades; R Hines; G Kopf; P Kraker; L Li; R O'Hara; C Rinder; H Rinder; R Shaw; B Smith; G Stahl; S K Shernan
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

7.  C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog.

Authors:  A Salvatierra; F Velasco; M Rodriguez; A Alvarez; R Lopez-Pedrera; R Ramirez; J Carracedo; F Lopez-Rubio; J Lopez-Pujol; R Guerrero
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

8.  Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits.

Authors:  W Ito; H J Schäfer; S Bhakdi; R Klask; S Hansen; S Schaarschmidt; J Schofer; F Hugo; T Hamdoch; D Mathey
Journal:  Cardiovasc Res       Date:  1996-08       Impact factor: 10.787

9.  Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy.

Authors:  A P Vakeva; A Agah; S A Rollins; L A Matis; L Li; G L Stahl
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

10.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

Authors:  M R Weiser; J P Williams; F D Moore; L Kobzik; M Ma; H B Hechtman; M C Carroll
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307
View more
  34 in total

Review 1.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

2.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

4.  Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.

Authors:  N Chun; R L Fairchild; Y Li; J Liu; M Zhang; W M Baldwin; P S Heeger
Journal:  Am J Transplant       Date:  2017-05-30       Impact factor: 8.086

5.  Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury.

Authors:  Maria Kovalska; Libusa Kovalska; Martina Pavlikova; Maria Janickova; Katarina Mikuskova; Marian Adamkov; Peter Kaplan; Zuzana Tatarkova; Jan Lehotsky
Journal:  Neurochem Res       Date:  2012-03-20       Impact factor: 3.996

Review 6.  Cortical spreading depression modifies components of the inflammatory cascade.

Authors:  Charlie S Thompson; Antoine M Hakim
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

7.  Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts.

Authors:  Carl Atkinson; Bernhard Floerchinger; Fei Qiao; Sarah Casey; Tucker Williamson; Ellen Moseley; Serban Stoica; Martin Goddard; Xupeng Ge; Stefan G Tullius; Stephen Tomlinson
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

8.  The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

Authors:  Maria Grazia De Simoni; Emanuela Rossi; Claudio Storini; Simone Pizzimenti; Cinara Echart; Luigi Bergamaschini
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.

Authors:  Madhu V Singh; Ann Kapoun; Linda Higgins; William Kutschke; Joshua M Thurman; Rong Zhang; Minati Singh; Jinying Yang; Xiaoqun Guan; John S Lowe; Robert M Weiss; Kathy Zimmermann; Fiona E Yull; Timothy S Blackwell; Peter J Mohler; Mark E Anderson
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

10.  Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.

Authors:  Anush V Karapetyan; Yuri M Klyachkin; Samy Selim; Manjula Sunkara; Khaled M Ziada; Donald A Cohen; Ewa K Zuba-Surma; Janina Ratajczak; Susan S Smyth; Mariusz Z Ratajczak; Andrew J Morris; Ahmed Abdel-Latif
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.